5 mg of tirzepatide is 50 units at the common 10 mg/mL concentration (a 10 mg vial in 1 mL of BAC water)
The entire vial was used within 8 weeks, well within the stability window
NNMT is an enzyme involved in nicotinamide metabolism and energy-related pathways
Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
How do I interpret the amount per 0.1 mL result
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties
